Sentiment-Signal
19,6
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Stammdaten
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
Unternehmen & Branche
| Name | ASP Isotopes Inc. |
|---|---|
| Ticker | ASPI |
| CIK | 0001921865 |
| Boerse | US |
| Sektor | Basic Materials |
| Industrie | Chemicals |
| SIC | 2890 · Miscellaneous Chemical Products |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 409,3 Mio. USD |
| Beta | 3,61 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 23,849,000 | -159,843,000 | -2.11 | 498,020,000 | 204,151,000 |
| 2025-09-30 | 10-Q | 4,889,526 | -12,893,602 | -0.15 | 225,890,161 | 74,068,517 |
| 2025-06-30 | 10-Q | 1,198,345 | -75,157,159 | -1.03 | 135,914,492 | 25,231,959 |
| 2025-03-31 | 10-Q | 1,101,605 | -8,461,432 | -0.12 | 90,873,659 | 42,512,697 |
| 2024-12-31 | 10-K | 4,144,000 | -32,423,000 | -0.63 | 94,348,000 | 47,899,000 |
| 2024-09-30 | 10-Q | 1,087,695 | -7,355,389 | -0.12 | 84,125,743 | 38,695,037 |
| 2024-06-30 | 10-Q | 1,022,299 | -8,881,442 | -0.24 | 54,760,934 | 11,011,480 |
| 2024-03-31 | 10-Q | 840,354 | -6,964,844 | -0.16 | 45,385,444 | 10,517,794 |
| 2023-12-31 | 10-K | 433,026 | -16,294,126 | -0.49 | 27,541,913 | 16,295,954 |
| 2023-09-30 | 10-Q | 0 | -4,222,483 | -0.14 | 11,871,392 | 8,639,487 |
| 2023-06-30 | 10-Q | 0 | -4,286,346 | 12,750,798 | 10,153,699 | |
| 2023-03-31 | 10-Q | 0 | -3,615,078 | 14,606,200 | 11,911,809 | |
| 2022-12-31 | 10-K | 0 | -4,945,139 | 12,496,265 | 9,817,461 | |
| 2022-09-30 | 10-Q | -1,956,230 | -0.06 | 9,481,238 | 6,318,218 | |
| 2022-06-30 | 10-Q | -827,170 | 7,408,537 | |||
| 2022-03-31 | 10-Q | -857,588 | 7,021,808 | |||
| 2021-12-31 | 10-K | -2,607,927 | 7,142,638 | 5,997,664 | ||
| 2021-09-30 | 10-Q | -508,247 | -0.18 | 2,055,677 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-16 | Ainscow Robert | Officer, COO | Open Market Sale | -22,500 | 5.21 | -117,112.50 | -52,0% | |
| 2026-04-16 | Moore Duncan | Director | Open Market Sale | -11,642 | 5.21 | -60,596.61 | -26,9% | |
| 2026-04-15 | Kiessling Heather | Officer, Chief Financial Officer | Open Market Sale | -23,124 | 5.48 | -126,673.27 | -56,2% | |
| 2026-03-06 | Ainscow Robert | Officer, COO | Open Market Sale | -8,438 | 5.44 | -45,894.28 | -20,4% | |
| 2026-03-06 | Ainscow Robert | Officer, COO | Open Market Sale | -25,000 | 4.51 | -112,775.00 | -50,0% | |
| 2025-12-18 | Kiessling Heather | Officer, Chief Financial Officer | Open Market Sale | -80,000 | 5.80 | -463,840.00 | -205,8% | |
| 2025-12-08 | Ainscow Robert | Officer, Interim CEO and COO | Open Market Sale | -8,438 | 6.20 | -52,340.91 | -23,2% | |
| 2025-11-25 | Ainscow Robert | Officer, Interim CEO and COO | Open Market Sale | -25,000 | 5.77 | -144,225.00 | -64,0% | |
| 2025-11-17 | Ainscow Robert | Officer, Interim CEO and COO | Open Market Sale | -67,500 | 7.51 | -506,722.50 | -224,8% | |
| 2025-10-14 | Ainscow Robert | Officer, Interim CEO and COO | Open Market Sale | -22,500 | 13.60 | -305,977.50 | -135,8% | |
| 2025-09-08 | Ainscow Robert | Officer, Chief Operating Officer | Open Market Sale | -8,438 | 8.53 | -71,944.92 | -31,9% | |
| 2025-08-29 | Moore Duncan | Director | Open Market Sale | -75,000 | 9.28 | -696,232.50 | -308,9% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.